Acute Q fever and the risk of developing endocarditis

Area of Science:

• Infectious Diseases
• Cardiology
• Immunology

Background:

• Acute Q fever, caused by *Coxiella burnetii*, can rarely lead to chronic complications like endocarditis.
• Early serological markers are crucial for predicting disease evolution and guiding treatment strategies.

Purpose of the Study:

• To evaluate if early clinical and serological data, specifically elevated phase I IgG antibodies, can predict the development of endocarditis following acute Q fever.
• To assess the impact of antibiotic treatment on the progression to chronic Q fever complications.

Main Methods:

• A retrospective cohort study involving 80 patients diagnosed with acute Q fever.
• Analysis of clinical data, serological antibody levels (phase I IgG), antibiotic treatments, and echocardiogram results.
• Median follow-up of 100 months to monitor for progression to endocarditis.

Main Results:

• 20% of patients exhibited high phase I IgG antibody levels (≥ 1:1024) within the first three months.
• Less than half of the patients received acute-phase antibiotic therapy, and only two received extended treatment.
• No patients developed symptoms of chronic infection or progressed to endocarditis during the follow-up period.

Conclusions:

• An early increase in phase I IgG antibodies in acute Q fever patients does not correlate with an increased risk of developing endocarditis.
• Prolonged antibiotic treatment was not necessary to prevent progression to endocarditis in this cohort.
• Clinical and serological monitoring may be sufficient for managing acute Q fever without routine extended antibiotic therapy.